GenEdit Announces Multiyear Collaboration and License Agreement with Genentech to Develop Novel Nanoparticles to Deliver Genetic Medicines for Autoimmune Disease | GenEdit

ImpriMed Raises $4M for Customized Cancer Treatments for Dogs

Precision medicine lowers the risks of treating lymphoma in dogs and eventually humans...

How to Assess Sensor Accuracy: MAE